Pfizer Falls, Paypal Gains, Stubhub Falls After Ratings Downgrade - podcast episode cover

Pfizer Falls, Paypal Gains, Stubhub Falls After Ratings Downgrade

Dec 16, 20253 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

On this episode of Stock Movers:
- Pfizer (PFE) shares fall after Pfizer forecasted little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions.
- Paypal (PYPL) shares gain after the company applied to become a bank in the US by submitting applications to the Federal Deposit Insurance Corp. and the Utah Department of Financial Institutions.
- Stubhub (STUB) shares fall after the company received a downgrade at Citizens, which predicts that the ticketing platform will face more robust competition in 2026 and flagged headwinds from regulation

See omnystudio.com/listener for privacy information.

Transcript

Speaker 1

Bloomberg Audio Studios, podcasts, radio news. The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data.

Speaker 2

Take a look at some of the stocks on the move today. I'm Paul Swen alongside SCARLOFILM.

Speaker 1

We're joined by Natal Bloomberg's Natalia Kenyan Jevich, Natali, what are you looking at today?

Speaker 2

Hi, guys. First, I'm looking at shares of Pfizer. The ticker is pf E. Shares are done by five point four percent as the company said that expects a little to know sales growth next year, So revenue in twenty twenty six is expected to be between fifty nine point five to sixty two point five billion dollars. Sales are

expected to be at sixty two billion dollars. So basically, we do know that Pfizer shares are kind of struggling to gain momentum as demand for COVID nineteen drugs is fading and there is a lot of competition across other drugs. So we do also know that the company is executing or trying to execute a big cost cutting effort. It targets more than seven billion dollars in savings by twenty twenty seven, and most of which it expects to complete

next year. On the bright side, however, we know that the company is trying to acquire more businesses, especially in a B city drug segment. All right, second stock, yes, so the share the next stop stop is stop. How the ticker is stub. Shares are done by five point almost six percent. Today, analysts from Citizens Cut downgraded the stock.

They cited competition and regulations. So first of all they said that there is a big headwinds coming from a competition with it with Vivid Seats for the market share, and then also regulation guys, there is a push to restrict resold tickets. Example, the UK ministers plan to ban the resale of tickets for live events above the original cost. So the stock is done, by the way, by more than forty percent. Since it's IPO, not going on Okay one more PayPal, the ticket is pypl. The shares are

up by almost two percent. Now. This comes as the company applied to become a bank in the United States. For some analysts, this move is logical because PayPal is already participating in the lending business and some other analysts are just setting favorable regulatory environment. However, the timeline is uncertain, so to some analysts it could take several years.

Speaker 1

The Stock Movers report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app MHM.

Transcript source: Provided by creator in RSS feed: download file
For the best experience, listen in Metacast app for iOS or Android